JPRN-UMIN000010312
Completed
未知
Evaluation of the efficacy and safety of intravitreal bimonthly injection of aflibercept for age-related macular degeneration - Bimonthly injection of aflibercept for age-related macular degeneration
Department of Ophthalmology, Shiga University of Medical Science0 sites40 target enrollmentApril 1, 2013
Conditionsage-related macular degeneration
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- age-related macular degeneration
- Sponsor
- Department of Ophthalmology, Shiga University of Medical Science
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with not active age\-related macular degeneration, severe glaucoma, inflammation disease, diabetic retinopathy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of the efficacy and safety of intravitreal injection of ranibizumab every other month for age-related macular degeneratioage-related macular degenerationJPRN-UMIN000005691Department of Ophthalmology, Shiga University of Medical Science40
Recruiting
Phase 3
Evaluation of efficacy of recombinant Tissue Plasminogen Activator on facility of vitrectomy for diabetic Tractional Retinal DetachmentIRCT20200217046522N1Iran University of Medical Sciences38
Recruiting
Phase 1
Placenta-derived mesenchymal stem cells and placenta-derived mesenchymal stem cells exosomes in the treatment of acute GvHDAcute GvHD.Graft-versus-host diseaseD89.81IRCT20140818018842N40Tehran University of Medical Sciences60
Completed
Phase 2
Evaluating the effects of intravenous immunoglobulin (IVIG) in COVID-19 patientsIRCT20151227025726N20Shahid Beheshti University of Medical Sciences80
Active, not recruiting
Phase 1
Study to Investigate the Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients with Iron Deficiency AnemiaEUCTR2019-003821-70-PLAmerican Regent, Inc.10